Medasys-Japan Licenses iPACS

Article

RealTimeImage, a provider of Internet-based streaming solutions, has entered a licensing agreement with Medasys-Japan, a

RealTimeImage, a provider of Internet-based streaming solutions, has entered a licensing agreement with Medasys-Japan, a developer and marketer of PACS. Under the agreement, Medasys will integrate RealTime's iPACS Enterprise into its DICOM-server products. The iPACS products allow immediate access to lossless diagnostic-quality images and image sequences over a wide range of bandwidths from simple telephone lines to fast LANs. No preprocessing or intermediate storage is required. Medasys-Japan has a large installed base of DICOM image viewer and teleradiology products. Founded in 1997 in Tokyo, Medasys-Japan is a division of Medasys, SA, headquartered in France, which develops PACS and electronic medical record and radiology information systems.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.